Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA
Article first published online: 25 DEC 2001
DOI: 10.1046/j.1365-2249.1998.00488.x
Blackwell Science Ltd, Oxford
Additional Information
How to Cite
Baskar, Collins, Dorsey-Cooper, Pyle, Nagel, Dwyer, Dunston, Johnson, Kendig, Israel, Nalin and Adler (1998), Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA. Clinical & Experimental Immunology, 111: 251–256. doi: 10.1046/j.1365-2249.1998.00488.x
Publication History
- Issue published online: 25 DEC 2001
- Article first published online: 25 DEC 2001
- Abstract
- Article
- References
- Cited By
Keywords:
- HIV-1;
- measles;
- indeterminate Western blot
Convalescent sera obtained from patients who were recently recovered from an acute measles virus infection were tested for the presence of anti-HIV-1 antibodies by Western blot analysis. While 16% (17/104) of control sera displayed reactive bands to a variety of HIV proteins, 62% (45/73) of convalescent sera demonstrated immunoreactive bands corresponding to HIV-1 Pol and Gag, but not Env antigens. This cross-reactivity appears to be the result of an active measles infection. No HIV-1 immunoblot reactivity (0/10) was observed in sera obtained from young adults several weeks after a combined measles, mumps, and rubella (MMR) vaccination. Interestingly, examination of anti-HLA typing sera specific for either class I and class II molecules revealed that 46% (19/41) of these sera contained cross-reactive antibodies to HIV-1 proteins. Absorption of measles sera with mixed lymphocyte reaction (MLR)-activated lymphocytes and/or HIV-1 recombinant proteins significantly decreased or removed the presence of these HIV-1-immunoreactive antibodies. Together, these findings suggest that the immune response to a natural measles virus infection results in the production of antibodies to HIV-1 and possibly autoantigens.

1365-2249/asset/cei_left.gif?v=1&s=ffee144c532fe5e73bbb89290ba14e154b0d400b)
1365-2249/asset/cei_right.gif?v=1&s=c14d545a5215173707c8202758d5b25fd0bede44)
1365-2249/asset/cover.gif?v=1&s=d4467d7f3170476372896b9f36344ab40422bf6f)